Product Images Alendronate Sodium

The text shows a chart with the cumulative incidence of Hip Fractures in a Three-Year Study of FIT, comparing Placebo with Alendronate Sodium for patients with radiographic vertebral fracture at baseline. The chart displays the results in percentage format over time in months.*

Osteoporosis Treatment Studies in Postmenopausal women comparing the effect of Alendronate Sodium 10mg/day versus Placebo on Lumbar Spine BMD Percent change from Baseline over time (in months). The study was conducted in both the US and internationally, as indicated by the two labeled columns. However, the data and statistics presented in the text are insufficient and difficult to interpret due to unclear formatting and missing values.*

This is a table with information on bone mineral density (BMD) change in postmenopausal women during 2-year and 3-year studies on osteoporosis prevention. The table includes mean percent changes and standard error (SE) in BMD from baseline, as well as sodium intake information. The BMD changes are listed for the lumbar spine, femoral neck, trochanter, and total body.*

This is a study on Paget's Disease of Bone comparing the effects of Alendronate Sodium 40 mg/day with Placebo or Etidronate 400 mg/day on the serum alkaline phosphatase. The study involved 27 participants and includes graphs showing the mean % change from baseline serum alkaline phosphatase levels over time.*